nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—GRM5—Parkinson's disease	0.703	0.864	CbGaD
Rufinamide—CYP2E1—Parkinson's disease	0.111	0.136	CbGaD
Rufinamide—GRM5—telencephalic ventricle—Parkinson's disease	0.00804	0.0819	CbGeAlD
Rufinamide—SCN8A—cerebellar cortex—Parkinson's disease	0.00778	0.0792	CbGeAlD
Rufinamide—SCN11A—peripheral nervous system—Parkinson's disease	0.00483	0.0492	CbGeAlD
Rufinamide—GRM5—hindbrain—Parkinson's disease	0.0038	0.0387	CbGeAlD
Rufinamide—SCN11A—nerve—Parkinson's disease	0.00376	0.0383	CbGeAlD
Rufinamide—SCN8A—peripheral nervous system—Parkinson's disease	0.00366	0.0373	CbGeAlD
Rufinamide—SCN8A—nerve—Parkinson's disease	0.00285	0.0291	CbGeAlD
Rufinamide—SCN10A—peripheral nervous system—Parkinson's disease	0.00245	0.0249	CbGeAlD
Rufinamide—GRM5—brainstem—Parkinson's disease	0.00218	0.0222	CbGeAlD
Rufinamide—SCN8A—hindbrain—Parkinson's disease	0.00214	0.0218	CbGeAlD
Rufinamide—GRM5—forebrain—Parkinson's disease	0.0021	0.0214	CbGeAlD
Rufinamide—SCN10A—nerve—Parkinson's disease	0.00191	0.0194	CbGeAlD
Rufinamide—SCN1A—hindbrain—Parkinson's disease	0.00162	0.0165	CbGeAlD
Rufinamide—SCN2A—hindbrain—Parkinson's disease	0.00148	0.0151	CbGeAlD
Rufinamide—GRM5—midbrain—Parkinson's disease	0.00139	0.0141	CbGeAlD
Rufinamide—GRM5—spinal cord—Parkinson's disease	0.00135	0.0138	CbGeAlD
Rufinamide—SCN8A—brainstem—Parkinson's disease	0.00122	0.0125	CbGeAlD
Rufinamide—GRM5—head—Parkinson's disease	0.0012	0.0122	CbGeAlD
Rufinamide—SCN8A—forebrain—Parkinson's disease	0.00118	0.012	CbGeAlD
Rufinamide—GRM5—nervous system—Parkinson's disease	0.00114	0.0116	CbGeAlD
Rufinamide—SCN7A—cardiovascular system—Parkinson's disease	0.00112	0.0114	CbGeAlD
Rufinamide—GRM5—central nervous system—Parkinson's disease	0.0011	0.0112	CbGeAlD
Rufinamide—GRM5—cerebellum—Parkinson's disease	0.00107	0.0109	CbGeAlD
Rufinamide—SCN11A—spinal cord—Parkinson's disease	0.001	0.0102	CbGeAlD
Rufinamide—SCN1A—brainstem—Parkinson's disease	0.000926	0.00943	CbGeAlD
Rufinamide—SCN1A—forebrain—Parkinson's disease	0.000893	0.0091	CbGeAlD
Rufinamide—SCN11A—head—Parkinson's disease	0.000893	0.00909	CbGeAlD
Rufinamide—GRM5—brain—Parkinson's disease	0.000872	0.00888	CbGeAlD
Rufinamide—SCN2A—brainstem—Parkinson's disease	0.00085	0.00865	CbGeAlD
Rufinamide—SCN11A—nervous system—Parkinson's disease	0.000847	0.00862	CbGeAlD
Rufinamide—SCN2A—forebrain—Parkinson's disease	0.00082	0.00835	CbGeAlD
Rufinamide—SCN11A—central nervous system—Parkinson's disease	0.000815	0.0083	CbGeAlD
Rufinamide—SCN10A—forebrain—Parkinson's disease	0.000791	0.00805	CbGeAlD
Rufinamide—SCN8A—spinal cord—Parkinson's disease	0.000761	0.00776	CbGeAlD
Rufinamide—SCN7A—head—Parkinson's disease	0.000759	0.00773	CbGeAlD
Rufinamide—SCN3A—forebrain—Parkinson's disease	0.000721	0.00734	CbGeAlD
Rufinamide—CES1—cardiovascular system—Parkinson's disease	0.0007	0.00713	CbGeAlD
Rufinamide—SCN9A—midbrain—Parkinson's disease	0.000686	0.00699	CbGeAlD
Rufinamide—SCN8A—head—Parkinson's disease	0.000677	0.00689	CbGeAlD
Rufinamide—SCN9A—spinal cord—Parkinson's disease	0.000669	0.00682	CbGeAlD
Rufinamide—SCN11A—brain—Parkinson's disease	0.000647	0.00659	CbGeAlD
Rufinamide—SCN1A—medulla oblongata—Parkinson's disease	0.000646	0.00657	CbGeAlD
Rufinamide—SCN8A—nervous system—Parkinson's disease	0.000642	0.00653	CbGeAlD
Rufinamide—SCN8A—central nervous system—Parkinson's disease	0.000618	0.00629	CbGeAlD
Rufinamide—SCN5A—cardiovascular system—Parkinson's disease	0.000608	0.00619	CbGeAlD
Rufinamide—SCN8A—cerebellum—Parkinson's disease	0.000604	0.00615	CbGeAlD
Rufinamide—SCN2A—medulla oblongata—Parkinson's disease	0.000592	0.00603	CbGeAlD
Rufinamide—SCN1A—midbrain—Parkinson's disease	0.00059	0.00601	CbGeAlD
Rufinamide—SCN1A—spinal cord—Parkinson's disease	0.000576	0.00586	CbGeAlD
Rufinamide—SCN7A—brain—Parkinson's disease	0.00055	0.0056	CbGeAlD
Rufinamide—SCN2A—midbrain—Parkinson's disease	0.000542	0.00552	CbGeAlD
Rufinamide—SCN4A—head—Parkinson's disease	0.000531	0.0054	CbGeAlD
Rufinamide—SCN2A—spinal cord—Parkinson's disease	0.000528	0.00538	CbGeAlD
Rufinamide—SCN3A—medulla oblongata—Parkinson's disease	0.000521	0.0053	CbGeAlD
Rufinamide—SCN1A—head—Parkinson's disease	0.000512	0.00521	CbGeAlD
Rufinamide—SCN10A—spinal cord—Parkinson's disease	0.000509	0.00519	CbGeAlD
Rufinamide—SCN4A—nervous system—Parkinson's disease	0.000503	0.00512	CbGeAlD
Rufinamide—SCN8A—brain—Parkinson's disease	0.00049	0.00499	CbGeAlD
Rufinamide—SCN1A—nervous system—Parkinson's disease	0.000485	0.00494	CbGeAlD
Rufinamide—SCN4A—central nervous system—Parkinson's disease	0.000484	0.00493	CbGeAlD
Rufinamide—SCN3A—midbrain—Parkinson's disease	0.000476	0.00485	CbGeAlD
Rufinamide—CES1—head—Parkinson's disease	0.000474	0.00483	CbGeAlD
Rufinamide—SCN2A—head—Parkinson's disease	0.00047	0.00478	CbGeAlD
Rufinamide—SCN1A—central nervous system—Parkinson's disease	0.000467	0.00476	CbGeAlD
Rufinamide—SCN3A—spinal cord—Parkinson's disease	0.000464	0.00473	CbGeAlD
Rufinamide—SCN1A—cerebellum—Parkinson's disease	0.000456	0.00465	CbGeAlD
Rufinamide—SCN10A—head—Parkinson's disease	0.000453	0.00461	CbGeAlD
Rufinamide—CES1—nervous system—Parkinson's disease	0.000449	0.00458	CbGeAlD
Rufinamide—SCN2A—nervous system—Parkinson's disease	0.000445	0.00453	CbGeAlD
Rufinamide—CES1—central nervous system—Parkinson's disease	0.000433	0.00441	CbGeAlD
Rufinamide—SCN9A—brain—Parkinson's disease	0.000431	0.00439	CbGeAlD
Rufinamide—SCN10A—nervous system—Parkinson's disease	0.000429	0.00437	CbGeAlD
Rufinamide—SCN2A—central nervous system—Parkinson's disease	0.000429	0.00437	CbGeAlD
Rufinamide—SCN2A—cerebellum—Parkinson's disease	0.000419	0.00427	CbGeAlD
Rufinamide—SCN10A—central nervous system—Parkinson's disease	0.000413	0.00421	CbGeAlD
Rufinamide—SCN3A—head—Parkinson's disease	0.000413	0.0042	CbGeAlD
Rufinamide—SCN5A—head—Parkinson's disease	0.000411	0.00419	CbGeAlD
Rufinamide—SCN3A—nervous system—Parkinson's disease	0.000391	0.00398	CbGeAlD
Rufinamide—SCN5A—nervous system—Parkinson's disease	0.00039	0.00397	CbGeAlD
Rufinamide—SCN4A—brain—Parkinson's disease	0.000384	0.00392	CbGeAlD
Rufinamide—SCN3A—central nervous system—Parkinson's disease	0.000377	0.00384	CbGeAlD
Rufinamide—SCN5A—central nervous system—Parkinson's disease	0.000376	0.00383	CbGeAlD
Rufinamide—SCN1A—brain—Parkinson's disease	0.000371	0.00378	CbGeAlD
Rufinamide—SCN3A—cerebellum—Parkinson's disease	0.000368	0.00375	CbGeAlD
Rufinamide—CES1—brain—Parkinson's disease	0.000343	0.0035	CbGeAlD
Rufinamide—SCN2A—brain—Parkinson's disease	0.00034	0.00347	CbGeAlD
Rufinamide—SCN10A—brain—Parkinson's disease	0.000328	0.00334	CbGeAlD
Rufinamide—SCN3A—brain—Parkinson's disease	0.000299	0.00305	CbGeAlD
Rufinamide—SCN5A—brain—Parkinson's disease	0.000298	0.00304	CbGeAlD
Rufinamide—CYP2E1—cardiovascular system—Parkinson's disease	0.000288	0.00293	CbGeAlD
Rufinamide—CYP2E1—medulla oblongata—Parkinson's disease	0.000246	0.0025	CbGeAlD
Rufinamide—ALB—brain—Parkinson's disease	0.000239	0.00243	CbGeAlD
Rufinamide—CYP2E1—spinal cord—Parkinson's disease	0.000219	0.00223	CbGeAlD
Rufinamide—CYP2E1—head—Parkinson's disease	0.000195	0.00198	CbGeAlD
Rufinamide—CYP2E1—nervous system—Parkinson's disease	0.000185	0.00188	CbGeAlD
Rufinamide—CYP2E1—central nervous system—Parkinson's disease	0.000178	0.00181	CbGeAlD
Rufinamide—CYP2E1—cerebellum—Parkinson's disease	0.000174	0.00177	CbGeAlD
Rufinamide—CYP3A4—nervous system—Parkinson's disease	0.000149	0.00151	CbGeAlD
Rufinamide—CYP3A4—central nervous system—Parkinson's disease	0.000143	0.00146	CbGeAlD
Rufinamide—CYP2E1—brain—Parkinson's disease	0.000141	0.00144	CbGeAlD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	7.44e-05	0.000843	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	7.39e-05	0.000837	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—IGF2—Parkinson's disease	7.37e-05	0.000835	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—EDN1—Parkinson's disease	7.37e-05	0.000835	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—INS—Parkinson's disease	7.36e-05	0.000834	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ABL1—Parkinson's disease	7.35e-05	0.000832	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	7.19e-05	0.000814	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—MTHFR—Parkinson's disease	7.18e-05	0.000813	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ABL1—Parkinson's disease	7.03e-05	0.000796	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	7.02e-05	0.000795	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	7.02e-05	0.000795	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	7.01e-05	0.000794	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—HGF—Parkinson's disease	6.96e-05	0.000788	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGF20—Parkinson's disease	6.94e-05	0.000786	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	6.83e-05	0.000773	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ABL1—Parkinson's disease	6.75e-05	0.000764	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ABL1—Parkinson's disease	6.75e-05	0.000764	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	6.74e-05	0.000763	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADORA2A—Parkinson's disease	6.73e-05	0.000762	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EDN1—Parkinson's disease	6.69e-05	0.000758	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	6.63e-05	0.000751	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—DOCK3—Parkinson's disease	6.6e-05	0.000747	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MERTK—Parkinson's disease	6.6e-05	0.000747	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—INS—Parkinson's disease	6.56e-05	0.000743	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ABL1—Parkinson's disease	6.51e-05	0.000737	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ABL1—Parkinson's disease	6.51e-05	0.000737	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	6.48e-05	0.000733	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	6.45e-05	0.00073	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ABL1—Parkinson's disease	6.41e-05	0.000726	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	6.33e-05	0.000717	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.25e-05	0.000708	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	6.24e-05	0.000707	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—INSR—Parkinson's disease	6.21e-05	0.000703	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	6.18e-05	0.0007	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	6.16e-05	0.000698	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	6.12e-05	0.000693	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—INS—Parkinson's disease	6e-05	0.00068	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—DGKQ—Parkinson's disease	5.88e-05	0.000666	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGB—Parkinson's disease	5.87e-05	0.000665	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR2A—Parkinson's disease	5.86e-05	0.000663	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR1A—Parkinson's disease	5.84e-05	0.000661	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TAC1—Parkinson's disease	5.75e-05	0.000651	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—DLG4—Parkinson's disease	5.74e-05	0.00065	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—INS—Parkinson's disease	5.71e-05	0.000646	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	5.7e-05	0.000646	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.67e-05	0.000643	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.66e-05	0.000641	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD1—Parkinson's disease	5.64e-05	0.000639	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	5.61e-05	0.000636	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	5.53e-05	0.000627	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD3—Parkinson's disease	5.46e-05	0.000618	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	5.32e-05	0.000602	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	5.23e-05	0.000593	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADRBK1—Parkinson's disease	5.1e-05	0.000577	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	5.09e-05	0.000577	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	5.09e-05	0.000577	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	5.06e-05	0.000573	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD2—Parkinson's disease	4.94e-05	0.000559	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR7—Parkinson's disease	4.94e-05	0.000559	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	4.89e-05	0.000554	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—INS—Parkinson's disease	4.85e-05	0.00055	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—COMT—Parkinson's disease	4.8e-05	0.000544	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	4.78e-05	0.000541	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	4.77e-05	0.00054	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	4.73e-05	0.000536	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	4.71e-05	0.000534	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—INS—Parkinson's disease	4.64e-05	0.000526	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	4.64e-05	0.000525	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ABL1—Parkinson's disease	4.58e-05	0.000518	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.55e-05	0.000516	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	4.53e-05	0.000513	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—IL6—Parkinson's disease	4.51e-05	0.000511	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—INS—Parkinson's disease	4.46e-05	0.000505	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—INS—Parkinson's disease	4.46e-05	0.000505	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	4.44e-05	0.000502	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	4.39e-05	0.000497	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	4.38e-05	0.000496	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	4.33e-05	0.00049	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—INS—Parkinson's disease	4.3e-05	0.000487	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—INS—Parkinson's disease	4.3e-05	0.000487	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL1B—Parkinson's disease	4.26e-05	0.000482	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	4.16e-05	0.000472	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF2—Parkinson's disease	4.14e-05	0.000469	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.12e-05	0.000466	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—IL6—Parkinson's disease	4.02e-05	0.000455	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1R—Parkinson's disease	4e-05	0.000453	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—Parkinson's disease	3.99e-05	0.000451	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	3.95e-05	0.000448	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EDN1—Parkinson's disease	3.95e-05	0.000448	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	3.8e-05	0.00043	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAG—Parkinson's disease	3.79e-05	0.000429	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6—Parkinson's disease	3.68e-05	0.000416	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NGF—Parkinson's disease	3.63e-05	0.000411	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—Parkinson's disease	3.55e-05	0.000402	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	3.49e-05	0.000395	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR2A—Parkinson's disease	3.46e-05	0.000392	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	3.44e-05	0.00039	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	3.38e-05	0.000383	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.32e-05	0.000376	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	3.27e-05	0.00037	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—Parkinson's disease	3.25e-05	0.000368	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6—Parkinson's disease	3.22e-05	0.000364	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APOE—Parkinson's disease	3.22e-05	0.000364	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ND3—Parkinson's disease	3.11e-05	0.000353	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MCCC1—Parkinson's disease	3.11e-05	0.000353	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—Parkinson's disease	3.09e-05	0.00035	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	3.09e-05	0.00035	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	3.07e-05	0.000347	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—INS—Parkinson's disease	3.02e-05	0.000342	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—Parkinson's disease	2.97e-05	0.000337	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.94e-05	0.000333	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—OMD—Parkinson's disease	2.93e-05	0.000331	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TALDO1—Parkinson's disease	2.93e-05	0.000331	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.9e-05	0.000328	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—Parkinson's disease	2.87e-05	0.000325	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—Parkinson's disease	2.84e-05	0.000322	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.84e-05	0.000322	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	2.77e-05	0.000314	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—INS—Parkinson's disease	2.75e-05	0.000311	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—Parkinson's disease	2.73e-05	0.000309	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—Parkinson's disease	2.73e-05	0.000309	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.7e-05	0.000306	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	2.69e-05	0.000304	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MCCC1—Parkinson's disease	2.68e-05	0.000303	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ND3—Parkinson's disease	2.68e-05	0.000303	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.65e-05	0.0003	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCH1—Parkinson's disease	2.65e-05	0.0003	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—Parkinson's disease	2.63e-05	0.000298	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—Parkinson's disease	2.63e-05	0.000298	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—Parkinson's disease	2.63e-05	0.000298	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—Parkinson's disease	2.62e-05	0.000297	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TALDO1—Parkinson's disease	2.52e-05	0.000285	CbGpPWpGaD
Rufinamide—ALB—Metabolism—OMD—Parkinson's disease	2.52e-05	0.000285	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—Parkinson's disease	2.51e-05	0.000285	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—Parkinson's disease	2.49e-05	0.000282	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	2.49e-05	0.000282	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	2.46e-05	0.000278	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—Parkinson's disease	2.42e-05	0.000274	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—Parkinson's disease	2.42e-05	0.000274	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FGB—Parkinson's disease	2.39e-05	0.000271	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NDUFB11—Parkinson's disease	2.38e-05	0.00027	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GBA—Parkinson's disease	2.36e-05	0.000267	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FBP1—Parkinson's disease	2.36e-05	0.000267	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DBH—Parkinson's disease	2.36e-05	0.000267	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—Parkinson's disease	2.33e-05	0.000264	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—Parkinson's disease	2.33e-05	0.000264	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCH1—Parkinson's disease	2.28e-05	0.000258	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.23e-05	0.000252	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.22e-05	0.000251	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.21e-05	0.00025	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.2e-05	0.000249	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.19e-05	0.000248	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—Parkinson's disease	2.12e-05	0.00024	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.05e-05	0.000232	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—Parkinson's disease	2.05e-05	0.000232	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.04e-05	0.000231	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—Parkinson's disease	2.03e-05	0.00023	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—Parkinson's disease	2.03e-05	0.00023	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FBP1—Parkinson's disease	2.03e-05	0.00023	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DBH—Parkinson's disease	2.03e-05	0.00023	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GBA—Parkinson's disease	2.03e-05	0.00023	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.01e-05	0.000228	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	1.98e-05	0.000224	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—Parkinson's disease	1.95e-05	0.000221	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—Parkinson's disease	1.95e-05	0.000221	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.88e-05	0.000213	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—Parkinson's disease	1.88e-05	0.000213	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—Parkinson's disease	1.88e-05	0.000213	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—Parkinson's disease	1.85e-05	0.00021	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SOD1—Parkinson's disease	1.77e-05	0.000201	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.77e-05	0.000201	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DDC—Parkinson's disease	1.73e-05	0.000196	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.7e-05	0.000193	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ABL1—Parkinson's disease	1.69e-05	0.000192	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF2—Parkinson's disease	1.69e-05	0.000191	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—Parkinson's disease	1.64e-05	0.000185	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.64e-05	0.000185	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HGF—Parkinson's disease	1.59e-05	0.00018	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DDC—Parkinson's disease	1.49e-05	0.000169	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.48e-05	0.000167	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.47e-05	0.000167	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.46e-05	0.000165	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ND3—Parkinson's disease	1.44e-05	0.000164	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.44e-05	0.000164	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.42e-05	0.000161	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA4—Parkinson's disease	1.41e-05	0.000159	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.39e-05	0.000157	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—OMD—Parkinson's disease	1.36e-05	0.000154	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.36e-05	0.000154	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—Parkinson's disease	1.32e-05	0.00015	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.29e-05	0.000146	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLA2G6—Parkinson's disease	1.27e-05	0.000143	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MAOB—Parkinson's disease	1.25e-05	0.000142	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.23e-05	0.000139	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—Parkinson's disease	1.2e-05	0.000136	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.19e-05	0.000135	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GBA—Parkinson's disease	1.09e-05	0.000124	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.09e-05	0.000124	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DBH—Parkinson's disease	1.09e-05	0.000124	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.08e-05	0.000123	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.06e-05	0.00012	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—Parkinson's disease	9.8e-06	0.000111	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TH—Parkinson's disease	9.66e-06	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2D6—Parkinson's disease	9.31e-06	0.000105	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYCS—Parkinson's disease	9.27e-06	0.000105	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CTGF—Parkinson's disease	9.14e-06	0.000103	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2E1—Parkinson's disease	8.52e-06	9.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—Parkinson's disease	8.42e-06	9.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TH—Parkinson's disease	8.3e-06	9.4e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COMT—Parkinson's disease	8.21e-06	9.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—Parkinson's disease	8.17e-06	9.25e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MAOA—Parkinson's disease	8.15e-06	9.23e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—Parkinson's disease	8.06e-06	9.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DDC—Parkinson's disease	8.03e-06	9.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYCS—Parkinson's disease	7.97e-06	9.02e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—Parkinson's disease	7.74e-06	8.76e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	7.59e-06	8.59e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—Parkinson's disease	7.51e-06	8.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—Parkinson's disease	7.19e-06	8.14e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COMT—Parkinson's disease	7.06e-06	7.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—Parkinson's disease	7.02e-06	7.95e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MAOA—Parkinson's disease	7.01e-06	7.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—Parkinson's disease	6.93e-06	7.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.83e-06	7.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.76e-06	7.66e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—Parkinson's disease	6.65e-06	7.53e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—Parkinson's disease	6.64e-06	7.52e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—Parkinson's disease	6.45e-06	7.31e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—Parkinson's disease	6.18e-06	7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—Parkinson's disease	6.18e-06	7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—Parkinson's disease	5.7e-06	6.46e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—Parkinson's disease	5.31e-06	6.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—INS—Parkinson's disease	5.28e-06	5.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.03e-06	5.69e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.93e-06	5.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.6e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.55e-06	5.15e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—INS—Parkinson's disease	4.54e-06	5.14e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TH—Parkinson's disease	4.48e-06	5.07e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.3e-06	4.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COMT—Parkinson's disease	3.81e-06	4.31e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.79e-06	4.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.78e-06	4.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.74e-06	4.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.59e-06	4.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.48e-06	3.95e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.34e-06	3.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.08e-06	3.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—Parkinson's disease	2.87e-06	3.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—INS—Parkinson's disease	2.45e-06	2.77e-05	CbGpPWpGaD
